Market Overview

UPDATE: JP Morgan Downgrades Dolby Laboratories to Underweight on Discouraging Outlook

Related DLB
Sony Pictures Home Entertainment and Dolby Announce Collaboration on Dolby Vision 4K Ultra HD
Benzinga's Volume Movers

JP Morgan reduced its rating on Dolby Laboratories (NYSE: DLB) from Neutral to Underweight and cut its price target from $48 to $43.50.

JP Morgan noted, "Unit sales across most of Dolby's licensing segments have slowed (smartphones excepted), and we are trimming FY12 estimates toward the mid-point of prior guidance, and to slightly below consensus. We believe DLB's revenues have stalled, with mobile-related licensing ramp merely offsetting declines in PC and CE segment royalties. Looking out to FY13 and CY13, we forecast flattish earnings and revenues, which does not justify a growth multiple, so we are trimming our price target to $43.50 based on 15 times CY13 PF EPS. DLB may be somewhat undervalued, but there is downside risk to estimates in our view, and lacking positive catalysts, we think the stock is likely to underperform the mean of our coverage universe, even if it is not a good candidate for shorting."

Dolby Laboratories closed at $35.50 on Tuesday.

Latest Ratings for DLB

Oct 2015B. RileyMaintainsNeutral
Apr 2015JP MorganUpgradesNeutralOverweight
Oct 2014JP MorganMaintainsNeutral

View More Analyst Ratings for DLB
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings


Related Articles (DLB)

View Comments and Join the Discussion!

Get Benzinga's Newsletters